TrademarkDir
PRECISIONIQ
DEAD

Serial Number

87036704

Owner

INTRINSIQ SPECIALTY SOLUTIONS, INC.

Attorney

Patrick C. Stephenson

First Use Date

Jun 5, 2019

Filing Date

May 13, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PRECISIONIQ Trademark

Serial Number: 87036704 • Registration: 5807221

PRECISIONIQ is a trademark filed by INTRINSIQ SPECIALTY SOLUTIONS, INC. on May 13, 2016. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

INTRINSIQ SPECIALTY SOLUTIONS, INC. (21 trademarks)

Carrollton, TX 75010

Entity Type: 03

Trademark Details

Filing Date

May 13, 2016

Registration Date

July 16, 2019

First Use Anywhere

June 5, 2019

First Use in Commerce

June 5, 2019

Published for Opposition

October 11, 2016

Cancellation Date

January 30, 2026

Goods & Services

providing a secured-access website featuring technology enabling access to aggregate, de-identified, patient and treatment data in the field of drug therapy; providing a secured-access website featuring technology enabling generation of customized reports of longitudinal data in medical assessment and treatment

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 30, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 16, 2024 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 17, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 17, 2021 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 20, 2019 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 20, 2019 COAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 20, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 20, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 12, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 11, 2019 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 11, 2019 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jun 10, 2019 SUPC
SOU EXTENSION 5 GRANTED
Jun 10, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 10, 2019 AITU
USE AMENDMENT FILED
Jun 6, 2019 IUAF
SOU EXTENSION 5 FILED
Jun 6, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Jun 6, 2019 EEXT
TEAS STATEMENT OF USE RECEIVED
Jun 6, 2019 EISU
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 20, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2019 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 5, 2018 EXRA
SOU EXTENSION 4 GRANTED
Dec 3, 2018 EX4G
SOU EXTENSION 4 FILED
Dec 3, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 3, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 22, 2018 EXRA
SOU EXTENSION 3 GRANTED
May 18, 2018 EX3G
SOU EXTENSION 3 FILED
May 18, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
May 18, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 8, 2017 EXRA
SOU EXTENSION 2 GRANTED
Dec 6, 2017 EX2G
SOU EXTENSION 2 FILED
Dec 6, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 6, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2017 EXRA
SOU EXTENSION 1 GRANTED
May 19, 2017 EX1G
SOU EXTENSION 1 FILED
May 19, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
May 19, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 6, 2016 NOAM
ASSIGNED TO EXAMINER
Nov 1, 2016 DOCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 11, 2016 NPUB
PUBLISHED FOR OPPOSITION
Oct 11, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 21, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2016 CNSA
ASSIGNED TO EXAMINER
Aug 30, 2016 DOCK
NOTICE OF PSEUDO MARK E-MAILED
May 19, 2016 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2016 NWOS
NEW APPLICATION ENTERED
May 17, 2016 NWAP

Related Trademarks

More from this Owner

ACTIVENGAGE

ACTIVENGAGE

ACTIVENGAGE

ACTIVENGAGE

INTELLIDOSETXM

INTELLIDOSETXM

INTELLIDOSETXM

INTELLIDOSETXM

INTELLIDOSETXM

INTELLIDOSETXM

CLINIQ PERSPECTIVES

CLINIQ PERSPECTIVES